Search

Silvana M Konermann

from San Diego, CA
Get Report
Related to:
Carla Rae Rice, 58Jake R Konermann, 24Doug Adams, 62Jordan W Pickens, 34Sara Renee Adams, 40
Connected to:
Joseph E Konerman, 67Jared A Konersman, 38Billie G Konert, 64Georgiana S Konert, 56Michelle L Konert, 62Aishwarya Koneru, 50Dheeraj Koneru, 49Keerthi Koneru, 44Krishna M Koneru, 48Madhuri Koneru, 43

Silvana Konermann Phones & Addresses

  • San Diego, CA
  • Cambridge, MA

Publications

Us Patents

Novel Crispr Enzymes And Systems

View page
US Patent:
20210348156, Nov 11, 2021
Filed:
Apr 30, 2021
Appl. No.:
17/246460
Inventors:
- Cambridge MA, US
- New Brunswick NJ, US
- Moscow, RU
- Bethesda MD, US
Leonid Minakhin - New Brunswick MD, US
Kira S. Makarova - Bethesda MD, US
Silvana Konermann - Cambridge MA, US
Julia Joung - Cambridge MA, US
Jonathan S. Gootenberg - Cambridge MA, US
Omar O. Abudayyeh - Cambridge MA, US
International Classification:
C12N 15/10
C12N 15/11
C12N 9/22
C12N 15/82
A61K 48/00
Abstract:
The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered DNA or RNA-targeting systems comprising a novel DNA or RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.

Novel Crispr Enzymes And Systems

View page
US Patent:
20210348157, Nov 11, 2021
Filed:
Apr 30, 2021
Appl. No.:
17/246466
Inventors:
- Cambridge MA, US
- New Brunswick NJ, US
- Moscow, RU
- Bethesda MD, US
Leonid Minakhin - New Brunswick MD, US
Kira S. Makarova - Bethesda MD, US
Silvana Konermann - Cambridge MA, US
Julia Joung - Cambridge MA, US
Jonathan S. Gootenberg - Cambridge MA, US
Omar O. Abudayyeh - Cambridge MA, US
International Classification:
C12N 15/10
C12N 15/11
C12N 9/22
C12N 15/82
A61K 48/00
Abstract:
The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered DNA or RNA-targeting systems comprising a novel DNA or RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.

Rna Targeting Methods And Compositions

View page
US Patent:
20200244609, Jul 30, 2020
Filed:
Jan 30, 2020
Appl. No.:
16/777604
Inventors:
- La Jolla CA, US
Silvana Konermann - San Diego CA, US
Assignee:
Salk Institute for Biological Studies - La Jolla CA
International Classification:
H04L 12/58
C12N 15/82
H04L 12/741
H04L 9/30
H04L 9/08
C12N 9/22
C12N 15/85
C12N 15/113
C12N 15/10
Abstract:
Provided herein are CRISPR/Cas methods and compositions for targeting RNA molecules, which can be used to detect, edit, or modify a target RNA.

Rna Targeting Methods And Compositions

View page
US Patent:
20200199556, Jun 25, 2020
Filed:
Feb 21, 2020
Appl. No.:
16/797969
Inventors:
- La Jolla CA, US
Silvana Konermann - San Diego CA, US
Assignee:
Salk Institute for Biological Studies - La Jolla CA
International Classification:
C12N 9/22
C12N 15/11
C12N 15/10
C12N 15/86
C12N 15/70
C12N 15/87
Abstract:
Provided herein are CRISPR/Cas methods and compositions for targeting RNA molecules, which can be used to detect, edit, or modify a target RNA.

Rna Targeting Methods And Compositions

View page
US Patent:
20200127954, Apr 23, 2020
Filed:
Dec 31, 2018
Appl. No.:
16/237381
Inventors:
- La Jolla CA, US
Silvana Konermann - San Diego CA, US
Assignee:
Salk Institute for Biological Studies - La Jolla
International Classification:
H04L 12/58
H04L 12/741
H04L 9/08
H04L 9/30
Abstract:
Provided herein are CRISPR/Cas methods and compositions for targeting RNA molecules, which can be used to detect, edit, or modify a target RNA.

Novel Crispr Enzymes And Systems

View page
US Patent:
20190382800, Dec 19, 2019
Filed:
Jun 24, 2019
Appl. No.:
16/450825
Inventors:
- Cambridge MA, US
- New Brunswick NJ, US
- Moscow, RU
- Bethesda MD, US
Kira S. Makarova - Bethesda MD, US
Eugene Koonin - Bethesda MD, US
Silvana Konermann - Cambridge MA, US
Julia Joung - Cambridge MA, US
Jonathan S. Gootenberg - Cambridge MA, US
Omar O. Abudayyeh - Cambridge MA, US
Eric S. Lander - Cambridge MA, US
International Classification:
C12N 15/90
C12N 15/113
C12N 15/85
C12N 15/82
C12N 15/11
C12N 9/22
C12N 15/10
Abstract:
The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered RNA-targeting systems comprising a novel RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.

Novel Crispr Enzymes And Systems

View page
US Patent:
20190382801, Dec 19, 2019
Filed:
Jun 24, 2019
Appl. No.:
16/450852
Inventors:
- Cambridge MA, US
- New Brunswick NJ, US
- Moscow, RU
- Bethesda MD, US
Kira S. Makarova - Bethesda MD, US
Eugene Koonin - Bethesda MD, US
Silvana Konermann - Cambridge MA, US
Julia Joung - Cambridge MA, US
Jonathan S. Gootenberg - Cambridge MA, US
Omar O. Abudayyeh - Cambridge MA, US
Eric S. Lander - Cambridge MA, US
International Classification:
C12N 15/90
C12N 15/10
C12N 9/22
C12N 15/11
C12N 15/82
C12N 15/85
C12N 15/113
Abstract:
The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered RNA-targeting systems comprising a novel RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.

Novel Crispr Enzymes And Systems

View page
US Patent:
20190345518, Nov 14, 2019
Filed:
Jun 24, 2019
Appl. No.:
16/450699
Inventors:
- Cambridge MA, US
- New Brunswick NJ, US
- Moscow, RU
- Bethesda MD, US
Kira S. Makarova - Bethesda MD, US
Eugene Koonin - Bethesda MD, US
Silvana Konermann - Cambridge MA, US
Julia Joung - Cambridge MA, US
Jonathan S. Gootenberg - Cambridge MA, US
Omar O. Abudayyeh - Cambridge MA, US
Eric S. Lander - Cambridge MA, US
International Classification:
C12N 15/90
C12N 15/85
C12N 15/10
C12N 15/63
C12N 15/113
C12N 9/22
C12N 15/82
C12N 15/11
Abstract:
The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered RNA-targeting systems comprising a novel RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.
Control profile
Silvana M Konermann from San Diego, CA Get Report